The PFAS Cleanup Bill Is Coming Due

Global PFAS filtration spend rises from $2.34B to $3.28B as EU rules trigger a decade of compliance investment

18 May 2026

Global spending on filters designed to remove "forever chemicals" from water is on course to reach $3.28bn by 2031, up from $2.34bn in 2026, as new drinking-water rules in the United States and European Union translate public health concern into binding procurement obligations, according to research published in February by MarketsandMarkets.

PFAS, or per- and polyfluoroalkyl substances, are a broad family of man-made chemicals used in industrial processes and consumer goods. They have been detected in drinking water, groundwater, and soil across every inhabited continent. The substances break down slowly in the environment and in the human body, giving rise to their colloquial designation.

Enforcement is driving the spending cycle. EU Drinking Water Directive limits on PFAS concentrations entered into force on 12 January 2026, prompting European utilities to move from passive monitoring into active procurement. North America holds roughly 42% of current global market revenue, shaped by years of Environmental Protection Agency enforcement activity and widespread civil litigation. Europe ranks second, with EU chemical regulations and national compliance mandates accelerating capital deployment across municipal water networks.

Granular activated carbon, a porous material that traps chemical contaminants, dominates the early phase of compliance, valued for its proven performance and rapid installation in high-throughput systems. Reverse osmosis membranes and nanofiltration technologies are forecast to grow fastest, at 7.7% annually, as stricter monitoring thresholds and expanding lists of regulated compounds push utilities toward more selective treatment solutions. Ion exchange resins and hybrid treatment systems are expected to gain ground over the medium term.

Veolia, AECOM, and Xylem are the leading companies in the market, each treating PFAS remediation as a core growth area. Specialist firms including Eurowater and Newterra are carving out targeted positions, an indication that commercial opportunity extends beyond large incumbents. Analysts note, however, that funding constraints and slow procurement timelines remain genuine barriers for smaller utilities, particularly those outside Europe's four largest markets.

Regulatory scope is widening. Broader panels of regulated PFAS compounds, rising environmental, social, and governance scrutiny from institutional investors, and tighter monitoring thresholds are expected to sustain demand well beyond the initial compliance phase. The market has passed the point where uptake depends on voluntary adoption; structural regulatory pressure now underpins the investment cycle.